GW Pharmaceuticals to present at Rodman & Renshaw Annual Global Investment Conference
GW Pharmaceuticals to present at Rodman and Renshaw Annual Global Investment Conference
10 September 2009
GW Pharmaceuticals plc (AIM: GWP) announces that its Managing Director, Justin Gover, will be presenting at the Rodman and Renshaw Annual Global Investment Conference in New York on Thursday, September 10, 2009 at 3.40 pm EDT (8.40 pm BST).
Investors may access a live webcast of the presentation at www.gwpharm.com on the presentations page under the Investor Relations tab. An archived version of the presentation will be available later that day.
Enquiries:
GW Pharmaceuticals pl: Today: +44 20 7831 3113
Justin Gover, Managing Director: Thereafter: + 44 1980 557000
Financial Dynamics: Tel: +44 20 7831 3113
Ben Atwell, John Dineen
Notes to Editors
About GW
GW was founded in 1998 and listed on the AIM, a market of the London Stock Exchange, in June 2001. Operating under license from the UK Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious ailments, in particular multiple sclerosis and cancer pain. GW has assembled a large in-house scientific team with expertise in cannabinoid science as well as experience in the development of both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field. For more information, visit www.gwpharm.com